
|Articles|October 1, 2003
PHASE I TRIALS FOR PSORAXINE
Astralis has begun Phase I clinical trial for Psoraxine for the treatment of moderate plaque psoriasis.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
5



















